Targeting the PI3K-AKT-mTOR signaling network in cancer

od Khan, Khurum H., Yap, Timothy A., Yan, Li, Cunningham, David
Wydane 2013

Assessment of fertility control efforts in a selected area of Karachi, Pakistan

od Shirmeen, Amra, Khan, Muhammad FH, Khan, Khizer H, Khan, Khurum H
Wydane 2007

Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Mana...

od Khan, Khurum H., Wong, Mabel, Rihawi, Karim, Bodla, Shankar, Morganstein, Daniel, Banerji, Udai, Molife, Lulama R.
Wydane w Oncologist (2016)

Longitudinal liquid biopsy and mathematical modelling of clonal evolution forecast waiting time to treatment failure in the PROSPECT-C phase II colorectal cancer clinical trial

od Khan, Khurum H, Cunningham, David, Werner, Benjamin, Vlachogiannis, Georgios, Spiteri, Inmaculada, Heide, Timon, Mateos, Javier Fernandez, Vatsiou, Alexandra, Lampis, Andrea, Damavandi, Mahnaz Darvish, Lote, Hazel, Huntingford, Ian S., Hedayat, Somaieh, Chau, Ian, Tunariu, Nina, Mentrasti, Giulia, Trevisani, Francesco, Rao, Sheela, Anandappa, Gayathri, Watkins, David, Starling, Naureen, Thomas, Janet, Peckitt, Clare, Khan, Nasir, Rugge, Massimo, Begum, Ruwaida, Hezelova, Blanka, Bryant, Annette, Jones, Thomas, Proszek, Paula, Fassan, Matteo, Hahne, Jens C, Hubank, Michael, Braconi, Chiara, Sottoriva, Andrea, Valeri, Nicola
Wydane w Cancer Discov (2018)